SEC
PRAH

Seven Eight Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Seven Eight Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,366
Closed -$3.69M – 784
2021
Q2 		$3.69M Buy
+22,366
New +$3.73M 0.52% 30
2020
Q1 		– Sell
-25,191
Closed -$2.8M – 786
2019
Q4 		$2.8M Sell
25,191
-10,600
-30% -$1.09M 0.15% 210
2019
Q3 		$3.55M Sell
35,791
-5,709
-14% -$567K 0.19% 158
2019
Q2 		$4.12M Buy
41,500
+31,300
+307% +$2.99M 0.22% 141
2019
Q1 		$1.13M Sell
10,200
-400
-4% -$41.8K 0.06% 346
2018
Q4 		$975K Sell
10,600
-15,800
-60% -$1.6M 0.05% 352
2018
Q3 		$2.91M Buy
+26,400
New +$2.75M 0.18% 175
2018
Q1 		– Sell
-2,900
Closed -$264K – 591
2017
Q4 		$264K Sell
2,900
-22,000
-88% -$1.83M 0.03% 406
2017
Q3 		$1.9M Buy
24,900
+13,700
+122% +$1.04M 0.23% 149
2017
Q2 		$840K Buy
+11,200
New +$776K 0.12% 234
2017
Q1 		– Sell
-4,400
Closed -$243K – 727
2016
Q4 		$243K Buy
+4,400
New +$241K 0.05% 386

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Seven Eight Capital's PRAH Position: Q3 2021 in Review

Seven Eight Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 22,366 shares — an estimated $3.69M sold.

Seven Eight Capital first reported a position in PRAH in Q4 2016 and held it in 11 quarters. The position peaked at $4.12M in Q2 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Seven Eight Capital reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Seven Eight Capital sold 22,366 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $3.69M.
  • Seven Eight Capital first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 11 quarters.
  • Seven Eight Capital's PRA Health Sciences, Inc. position peaked at $4.12M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Seven Eight Capital's 13F filing for Q3 2021, filed 15 Nov 2021.